Skip to main content
Top
Published in: Journal of Translational Medicine 1/2013

Open Access 01-12-2013 | Research

The role of globular heads of the C1q receptor in HPV 16 E2-induced human cervical squamous carcinoma cell apoptosis is associated with p38 MAPK/JNK activation

Authors: Ling-juan Gao, Ping-qing Gu, Wei Zhao, Wen-yan Ding, Xue-qing Zhao, Shu-yu Guo, Tian-ying Zhong

Published in: Journal of Translational Medicine | Issue 1/2013

Login to get access

Abstract

Background

Human papillomavirus type 16 (HPV 16) E2 protein is a multifunctional DNA-binding protein. HPV 16 E2 regulates many biological responses, including DNA replication, gene expression, and apoptosis. The purpose of this study was to investigate the relationship among the receptor for globular heads of the human C1q (gC1qR) gene expression, HPV 16 E2 transfection and apoptosis regulation in human cervical squamous carcinoma cells (C33a and SiHa).

Methods

gC1qR expression was examined in C33a and SiHa cells using real-time PCR and Western blot analysis. Apoptosis of C33a and SiHa cells was assessed by flow cytometry. C33a and SiHa cell viability, migration and proliferation were detected using the water-soluble tetrazolium salt (WST-1) assay, a transwell assay and 3H-thymidine incorporation into DNA (3H-TdR), respectively.

Results

C33a and SiHa cells that were transfected with a vector encoding HPV 16 E2 displayed significantly increased gC1qR gene expression and p38 mitogen-activated protein kinase (p38 MAPK)/ c-jun N-terminal kinase (JNK) activation as well as up-regulation of cellular apoptosis, which was abrogated by the addition of gC1qR small interfering RNA (siRNA). Furthermore, the changes in C33a and SiHa cell viability, migration and proliferation that were observed upon HPV 16 E2 transfection were abrogated by SB203580 (a p38 MAPK inhibitor) or SP600125 (a JNK inhibitor) treatment.

Conclusion

These data support a mechanism whereby HPV 16 E2 induces apoptosis by silencing the gC1qR gene or inhibiting p38 MAPK/JNK signalling in cervical squamous cell carcinoma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pruski D, Fraszczak J, Iwaniec K, Przybylski M, Kedzia W, Gretkiewicz-Tomczyk A, Karowicz-Bilińska A, Spaczyński M: Assessment of frequency of regression and progression of mild cervical neoplasia- LGSIL in women with positive high-risk HPV DNA test result. Ginekol Pol. 2012, 83: 572-575.PubMed Pruski D, Fraszczak J, Iwaniec K, Przybylski M, Kedzia W, Gretkiewicz-Tomczyk A, Karowicz-Bilińska A, Spaczyński M: Assessment of frequency of regression and progression of mild cervical neoplasia- LGSIL in women with positive high-risk HPV DNA test result. Ginekol Pol. 2012, 83: 572-575.PubMed
2.
go back to reference Chay DB, Cho H, Kim BW, Kang ES, Song E, Kim JH: Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia. Obstet Gynecol. 2013, 121: 321-329.PubMed Chay DB, Cho H, Kim BW, Kang ES, Song E, Kim JH: Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia. Obstet Gynecol. 2013, 121: 321-329.PubMed
3.
go back to reference Broccolo F, Fusetti L, Rosini S, Caraceni D, Zappacosta R, Ciccocioppo L, Matteoli B, Halfon P, Malnati MS, Ceccherini-Nelli L: Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: Results from a multicenter study. J Med Virol. 2013, 85: 472-482. 10.1002/jmv.23487.CrossRefPubMed Broccolo F, Fusetti L, Rosini S, Caraceni D, Zappacosta R, Ciccocioppo L, Matteoli B, Halfon P, Malnati MS, Ceccherini-Nelli L: Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: Results from a multicenter study. J Med Virol. 2013, 85: 472-482. 10.1002/jmv.23487.CrossRefPubMed
4.
go back to reference Altinbas SK, Tapisiz OL: Human papillomavirus, vaccines, and protection from cervical cancer. Saudi Med J. 2012, 33: 1270-1277.PubMed Altinbas SK, Tapisiz OL: Human papillomavirus, vaccines, and protection from cervical cancer. Saudi Med J. 2012, 33: 1270-1277.PubMed
5.
go back to reference Naryshkin S, Austin RM: Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening. Drug Healthc Patient Saf. 2012, 4: 167-172.PubMedCentralCrossRefPubMed Naryshkin S, Austin RM: Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening. Drug Healthc Patient Saf. 2012, 4: 167-172.PubMedCentralCrossRefPubMed
6.
go back to reference Johansson C, Somberg M, Li X, Backström Winquist E, Fay J, Ryan F, Pim D, Banks L, Schwartz S: HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation. EMBO J. 2012, 31: 3212-3227. 10.1038/emboj.2012.147.PubMedCentralCrossRefPubMed Johansson C, Somberg M, Li X, Backström Winquist E, Fay J, Ryan F, Pim D, Banks L, Schwartz S: HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation. EMBO J. 2012, 31: 3212-3227. 10.1038/emboj.2012.147.PubMedCentralCrossRefPubMed
7.
go back to reference Chansaenroj J, Theamboonlers A, Junyangdikul P, Swangvaree S, Karalak A, Poovorawan Y: Whole genome analysis of human papillomavirus type 16 multiple infection in cervical cancer patients. Asian Pac J Cancer Prev. 2012, 13: 599-606. 10.7314/APJCP.2012.13.2.599.CrossRefPubMed Chansaenroj J, Theamboonlers A, Junyangdikul P, Swangvaree S, Karalak A, Poovorawan Y: Whole genome analysis of human papillomavirus type 16 multiple infection in cervical cancer patients. Asian Pac J Cancer Prev. 2012, 13: 599-606. 10.7314/APJCP.2012.13.2.599.CrossRefPubMed
8.
go back to reference Nogara PR, Gimenes F, Consolaro ME: Distribution of HPV genotypes and HPV-16 and HPV-18 E2 gene disruption in South Brazilian women with cervical abnormalities. Int J Gynaecol Obstet. 2012, 117: 289-290. 10.1016/j.ijgo.2012.01.003.CrossRefPubMed Nogara PR, Gimenes F, Consolaro ME: Distribution of HPV genotypes and HPV-16 and HPV-18 E2 gene disruption in South Brazilian women with cervical abnormalities. Int J Gynaecol Obstet. 2012, 117: 289-290. 10.1016/j.ijgo.2012.01.003.CrossRefPubMed
9.
go back to reference Magaldi TG, Almstead LL, Bellone S, Prevatt EG, Santin AD, DiMaio D: Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Virology. 2012, 422: 114-124. 10.1016/j.virol.2011.10.012.PubMedCentralCrossRefPubMed Magaldi TG, Almstead LL, Bellone S, Prevatt EG, Santin AD, DiMaio D: Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Virology. 2012, 422: 114-124. 10.1016/j.virol.2011.10.012.PubMedCentralCrossRefPubMed
10.
go back to reference Patel S, Chiplunkar S: Host immune responses to cervical cancer. Curr Opin Obstet Gynecol. 2009, 21: 54-59. 10.1097/GCO.0b013e32831a9890.CrossRefPubMed Patel S, Chiplunkar S: Host immune responses to cervical cancer. Curr Opin Obstet Gynecol. 2009, 21: 54-59. 10.1097/GCO.0b013e32831a9890.CrossRefPubMed
11.
go back to reference Holzinger D, Schmitt M, Dyckhoff G, Benner A, Pawlita M, Bosch FX: Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. Cancer Res. 2012, 72: 4993-5003. 10.1158/0008-5472.CAN-11-3934.CrossRefPubMed Holzinger D, Schmitt M, Dyckhoff G, Benner A, Pawlita M, Bosch FX: Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. Cancer Res. 2012, 72: 4993-5003. 10.1158/0008-5472.CAN-11-3934.CrossRefPubMed
12.
go back to reference Mahasiripanth T, Hokputsa S, Niruthisard S, Bhattarakosol P, Patumraj S: Effects of Acanthus ebracteatus Vahl on tumor angiogenesis and on tumor growth in nude mice implanted with cervical cancer. Cancer Manag Res. 2012, 4: 269-279.PubMedCentralPubMed Mahasiripanth T, Hokputsa S, Niruthisard S, Bhattarakosol P, Patumraj S: Effects of Acanthus ebracteatus Vahl on tumor angiogenesis and on tumor growth in nude mice implanted with cervical cancer. Cancer Manag Res. 2012, 4: 269-279.PubMedCentralPubMed
13.
go back to reference Deng Z, Hasegawa M, Yamashita Y, Matayoshi S, Kiyuna A, Agena S, Uehara T, Maeda H, Suzuki M: Prognostic value of human papillomavirus and squamous cell carcinoma antigen in head and neck squamous cell carcinoma. Cancer Sci. 2012, 103: 2127-2134. 10.1111/cas.12009.CrossRefPubMed Deng Z, Hasegawa M, Yamashita Y, Matayoshi S, Kiyuna A, Agena S, Uehara T, Maeda H, Suzuki M: Prognostic value of human papillomavirus and squamous cell carcinoma antigen in head and neck squamous cell carcinoma. Cancer Sci. 2012, 103: 2127-2134. 10.1111/cas.12009.CrossRefPubMed
14.
go back to reference Yagi M, Uchiumi T, Takazaki S, Okuno B, Nomura M, Yoshida S, Kanki T, Kang D: p32/gC1qR is indispensable for fetal development and mitochondrial translation: importance of its RNA-binding ability. Nucleic Acids Res. 2012, 40: 9717-9737. 10.1093/nar/gks774.PubMedCentralCrossRefPubMed Yagi M, Uchiumi T, Takazaki S, Okuno B, Nomura M, Yoshida S, Kanki T, Kang D: p32/gC1qR is indispensable for fetal development and mitochondrial translation: importance of its RNA-binding ability. Nucleic Acids Res. 2012, 40: 9717-9737. 10.1093/nar/gks774.PubMedCentralCrossRefPubMed
15.
go back to reference van Leeuwen HC, O’Hare P: Retargeting of the mitochondrial protein p32/gC1Qr to a cytoplasmic compartment and the cell surface. J Cell Sci. 2001, 114: 2115-2123.PubMed van Leeuwen HC, O’Hare P: Retargeting of the mitochondrial protein p32/gC1Qr to a cytoplasmic compartment and the cell surface. J Cell Sci. 2001, 114: 2115-2123.PubMed
16.
go back to reference Chen ZL, Gu PQ, Liu K, Su YJ, Gao LJ: The globular heads of the C1q receptor regulate apoptosis in human cervical squamous carcinoma cells via a p53-dependent pathway. J Transl Med. 2012, 10: 255-10.1186/1479-5876-10-255.PubMedCentralCrossRefPubMed Chen ZL, Gu PQ, Liu K, Su YJ, Gao LJ: The globular heads of the C1q receptor regulate apoptosis in human cervical squamous carcinoma cells via a p53-dependent pathway. J Transl Med. 2012, 10: 255-10.1186/1479-5876-10-255.PubMedCentralCrossRefPubMed
17.
go back to reference Liu Z, Su YJ, Gu PQ, Ji ZY, Wang XG, Gao LJ: The role of the globular heads of C1q receptor (gC1qR) gene in regulating apoptosis of human cervical squamous cell carcinoma. Cell Physiol Biochem. 2012, 30: 1181-1190. 10.1159/000343308.CrossRefPubMed Liu Z, Su YJ, Gu PQ, Ji ZY, Wang XG, Gao LJ: The role of the globular heads of C1q receptor (gC1qR) gene in regulating apoptosis of human cervical squamous cell carcinoma. Cell Physiol Biochem. 2012, 30: 1181-1190. 10.1159/000343308.CrossRefPubMed
18.
go back to reference Balbi G, Napolitano A, Giordano F, Capuano S, Manganaro MA, Di Martino L, Fusco D, Grauso F, Seguino E: Role of the association of high-risk HPV identified by real-time PCR in cervical preneoplastic lesions. Eur J Gynaecol Oncol. 2012, 33: 467-471.PubMed Balbi G, Napolitano A, Giordano F, Capuano S, Manganaro MA, Di Martino L, Fusco D, Grauso F, Seguino E: Role of the association of high-risk HPV identified by real-time PCR in cervical preneoplastic lesions. Eur J Gynaecol Oncol. 2012, 33: 467-471.PubMed
19.
go back to reference Ca L, A C, E M, D P, S M, J DI, A Z, G G, G B: High risk HPV DNA subtypes and E6/E7 mRNA expression in a cohort of colposcopy patients from Northern Italy with high-grade histologically verified cervical lesions. Am J Transl Res. 2012, 4: 452-457.PubMedCentralPubMed Ca L, A C, E M, D P, S M, J DI, A Z, G G, G B: High risk HPV DNA subtypes and E6/E7 mRNA expression in a cohort of colposcopy patients from Northern Italy with high-grade histologically verified cervical lesions. Am J Transl Res. 2012, 4: 452-457.PubMedCentralPubMed
20.
go back to reference Mu¨nger K, Howley PM: Human papillomavirus immortalization and transformation functions. Virus Res. 2002, 89: 213-228. 10.1016/S0168-1702(02)00190-9.CrossRef Mu¨nger K, Howley PM: Human papillomavirus immortalization and transformation functions. Virus Res. 2002, 89: 213-228. 10.1016/S0168-1702(02)00190-9.CrossRef
21.
go back to reference Mu¨nger K, Phelps WC, Bubb V, Howley PM, Schlegel R: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 1989, 63: 4417-4421. Mu¨nger K, Phelps WC, Bubb V, Howley PM, Schlegel R: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 1989, 63: 4417-4421.
22.
go back to reference McCloskey R, Menges C, Friedman A, Patel D, McCance DJ: Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation. J Virol. 2010, 84: 5131-5139. 10.1128/JVI.01965-09.PubMedCentralCrossRefPubMed McCloskey R, Menges C, Friedman A, Patel D, McCance DJ: Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation. J Virol. 2010, 84: 5131-5139. 10.1128/JVI.01965-09.PubMedCentralCrossRefPubMed
23.
go back to reference Longworth MS, Laimins LA: Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev. 2004, 68: 362-372. 10.1128/MMBR.68.2.362-372.2004.PubMedCentralCrossRefPubMed Longworth MS, Laimins LA: Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev. 2004, 68: 362-372. 10.1128/MMBR.68.2.362-372.2004.PubMedCentralCrossRefPubMed
24.
go back to reference Menges CW, Baglia LA, Lapoint R, McCance DJ: Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res. 2006, 66: 5555-5559. 10.1158/0008-5472.CAN-06-0499.CrossRefPubMed Menges CW, Baglia LA, Lapoint R, McCance DJ: Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res. 2006, 66: 5555-5559. 10.1158/0008-5472.CAN-06-0499.CrossRefPubMed
25.
go back to reference Patel D, Incassati A, Wang N, McCance DJ: Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M-phase proteins. Cancer Res. 2004, 64: 1299-1306. 10.1158/0008-5472.CAN-03-2917.CrossRefPubMed Patel D, Incassati A, Wang N, McCance DJ: Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M-phase proteins. Cancer Res. 2004, 64: 1299-1306. 10.1158/0008-5472.CAN-03-2917.CrossRefPubMed
26.
go back to reference Chang SW, Lu PY, Guo JH, Tsai TC, Tsao YP, Chen SL: NRIP enhances HPV gene expression via interaction with either GR or E2. Virology. 2012, 423: 38-48. 10.1016/j.virol.2011.11.015.CrossRefPubMed Chang SW, Lu PY, Guo JH, Tsai TC, Tsao YP, Chen SL: NRIP enhances HPV gene expression via interaction with either GR or E2. Virology. 2012, 423: 38-48. 10.1016/j.virol.2011.11.015.CrossRefPubMed
27.
go back to reference Villota C, Campos A, Vidaurre S, Oliveira-Cruz L, Boccardo E, Burzio VA, Varas M, Villegas J, Villa LL, Valenzuela PD, Socías M, Roberts S, Burzio LO: Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes. J Biol Chem. 2012, 287: 21303-21315. 10.1074/jbc.M111.326694.PubMedCentralCrossRefPubMed Villota C, Campos A, Vidaurre S, Oliveira-Cruz L, Boccardo E, Burzio VA, Varas M, Villegas J, Villa LL, Valenzuela PD, Socías M, Roberts S, Burzio LO: Expression of mitochondrial non-coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes. J Biol Chem. 2012, 287: 21303-21315. 10.1074/jbc.M111.326694.PubMedCentralCrossRefPubMed
28.
go back to reference Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, Ruoslahti E: Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol. 2010, 30: 1303-1318. 10.1128/MCB.01101-09.PubMedCentralCrossRefPubMed Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, Ruoslahti E: Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol. 2010, 30: 1303-1318. 10.1128/MCB.01101-09.PubMedCentralCrossRefPubMed
29.
go back to reference Gao LJ, Gu PQ, Fan WM, Liu Z, Qiu F, Peng YZ, Guo XR: The role of gC1qR in regulating survival of human papillomavirus 16 oncogene-transfected cervical cancer cells. In J Oncol. 2011, 39: 1265-1272. Gao LJ, Gu PQ, Fan WM, Liu Z, Qiu F, Peng YZ, Guo XR: The role of gC1qR in regulating survival of human papillomavirus 16 oncogene-transfected cervical cancer cells. In J Oncol. 2011, 39: 1265-1272.
30.
go back to reference Ghebrehiwet B, Jesty J, Vinayagasundaram R, Vinayagasundaram U, Ji Y, Valentino A, Tumma N, Hosszu KH, Peerschke EI: Targeting gC1qR domains for therapy against infection and inflammation. Adv Exp Med Biol. 2013, 734: 97-110.CrossRef Ghebrehiwet B, Jesty J, Vinayagasundaram R, Vinayagasundaram U, Ji Y, Valentino A, Tumma N, Hosszu KH, Peerschke EI: Targeting gC1qR domains for therapy against infection and inflammation. Adv Exp Med Biol. 2013, 734: 97-110.CrossRef
31.
go back to reference Peerschke EI, Murphy TK, Ghebrehiwet B: Activation-dependent surface expression of gC1qR/p33 on human blood platelets. Thromb Haemost. 2003, 89: 331-339.PubMed Peerschke EI, Murphy TK, Ghebrehiwet B: Activation-dependent surface expression of gC1qR/p33 on human blood platelets. Thromb Haemost. 2003, 89: 331-339.PubMed
32.
go back to reference Peerschke EI, Ghebrehiwet B: The contribution of gC1qR/p33 in infection and inflammation. Immunobiology. 2007, 212: 333-342. 10.1016/j.imbio.2006.11.011.PubMedCentralCrossRefPubMed Peerschke EI, Ghebrehiwet B: The contribution of gC1qR/p33 in infection and inflammation. Immunobiology. 2007, 212: 333-342. 10.1016/j.imbio.2006.11.011.PubMedCentralCrossRefPubMed
33.
go back to reference Xu L, Xiao N, Liu F, Ren H, Gu J: Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. Proc Natl Acad Sci USA. 2009, 106: 1530-1535. 10.1073/pnas.0811029106.PubMedCentralCrossRefPubMed Xu L, Xiao N, Liu F, Ren H, Gu J: Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. Proc Natl Acad Sci USA. 2009, 106: 1530-1535. 10.1073/pnas.0811029106.PubMedCentralCrossRefPubMed
34.
go back to reference Kaul R, Saha P, Saradhi M, Prasad RL, Chatterjee S, Ghosh I, Tyagi RK, Datta K: Overexpression of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads to increased hyaluronan synthesis and cell proliferation by up-regulation of cyclin D1 in AKT-dependent pathway. J Biol Chem. 2012, 287: 19750-19764. 10.1074/jbc.M111.266270.PubMedCentralCrossRefPubMed Kaul R, Saha P, Saradhi M, Prasad RL, Chatterjee S, Ghosh I, Tyagi RK, Datta K: Overexpression of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) in HepG2 cells leads to increased hyaluronan synthesis and cell proliferation by up-regulation of cyclin D1 in AKT-dependent pathway. J Biol Chem. 2012, 287: 19750-19764. 10.1074/jbc.M111.266270.PubMedCentralCrossRefPubMed
35.
go back to reference Kumar V, Misro MM, Datta K: Simultaneous accumulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) and apoptotic induction of germ cells in cryptorchid testis. J Androl. 2012, 33: 114-121. 10.2164/jandrol.110.011320.CrossRefPubMed Kumar V, Misro MM, Datta K: Simultaneous accumulation of hyaluronan binding protein 1 (HABP1/p32/gC1qR) and apoptotic induction of germ cells in cryptorchid testis. J Androl. 2012, 33: 114-121. 10.2164/jandrol.110.011320.CrossRefPubMed
36.
go back to reference Vegh Z, Goyarts EC, Rozengarten K, Mazumder A, Ghebrehiwet B: Maturation-dependent expression of C1q binding protein on the cell surface of human monocyte-derived dendritic cells. Int Immunopharmacol. 2003, 3: 39-51. 10.1016/S1567-5769(02)00211-4.CrossRefPubMed Vegh Z, Goyarts EC, Rozengarten K, Mazumder A, Ghebrehiwet B: Maturation-dependent expression of C1q binding protein on the cell surface of human monocyte-derived dendritic cells. Int Immunopharmacol. 2003, 3: 39-51. 10.1016/S1567-5769(02)00211-4.CrossRefPubMed
37.
go back to reference Muta T, Kang D, Kitajima S, Fujiwara T, Hamasaki N: p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation. J Biol Chem. 1997, 272: 24363-24370. 10.1074/jbc.272.39.24363.CrossRefPubMed Muta T, Kang D, Kitajima S, Fujiwara T, Hamasaki N: p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation. J Biol Chem. 1997, 272: 24363-24370. 10.1074/jbc.272.39.24363.CrossRefPubMed
38.
go back to reference Lee KA, Cho KJ, Kim SH, Shim JH, Lim JS, Cho DH, Song MS, Dinarello CA, Yoo DY: IL-18 E42A mutant is resistant to the inhibitory effects of HPV-16 E6 and E7 oncogenes on the IL-18-mediated immune response. Cancer Lett. 2005, 229: 261-270. 10.1016/j.canlet.2005.06.042.CrossRefPubMed Lee KA, Cho KJ, Kim SH, Shim JH, Lim JS, Cho DH, Song MS, Dinarello CA, Yoo DY: IL-18 E42A mutant is resistant to the inhibitory effects of HPV-16 E6 and E7 oncogenes on the IL-18-mediated immune response. Cancer Lett. 2005, 229: 261-270. 10.1016/j.canlet.2005.06.042.CrossRefPubMed
Metadata
Title
The role of globular heads of the C1q receptor in HPV 16 E2-induced human cervical squamous carcinoma cell apoptosis is associated with p38 MAPK/JNK activation
Authors
Ling-juan Gao
Ping-qing Gu
Wei Zhao
Wen-yan Ding
Xue-qing Zhao
Shu-yu Guo
Tian-ying Zhong
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2013
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-11-118

Other articles of this Issue 1/2013

Journal of Translational Medicine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.